23 May 2013
Keywords: forthcoming, gsk, eltrombopag, data, review, conducted, financial
Article | 16 October 2006
A review, conducted by financial analysts Lehman Brothers, of abstract data due to be presented by UK drug major GlaxoSmithKline ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 October 2006
23 October 2006
9 October 2006
© 2013 thepharmaletter.com